| 201 |
19149538 | Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes. | 2009 Jan |
1 |
| 202 |
19174497 | Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes. | 2009 Apr |
1 |
| 203 |
19179813 | Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes. | 2009 Jan |
1 |
| 204 |
19275548 | Recent advances in antidiabetic drug therapies targeting the enteroinsular axis. | 2009 Feb |
2 |
| 205 |
19288260 | Drug evaluation: vildagliptin-metformin single-tablet combination. | 2009 Feb |
2 |
| 206 |
19330494 | Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. | 2009 Mar |
2 |
| 207 |
19364302 | Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes. | 2009 May |
2 |
| 208 |
19385979 | The scientific evidence: vildagliptin and the benefits of islet enhancement. | 2009 May |
1 |
| 209 |
19385980 | Translating science into clinical practice: focus on vildagliptin in combination with metformin. | 2009 May |
1 |
| 210 |
19418936 | [Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes]. | 2009 Mar |
1 |
| 211 |
19545590 | Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors. | 2009 Oct |
1 |
| 212 |
19581505 | Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. | 2009 Sep |
2 |
| 213 |
19705345 | Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes. | 2009 Dec |
1 |
| 214 |
19748065 | Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4). | 2009 Aug |
1 |
| 215 |
19755410 | Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation. | 2009 Dec |
1 |
| 216 |
19780719 | Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. | 2009 Sep 28 |
1 |
| 217 |
19874253 | Vildagliptin in clinical practice: a review of literature. | 2009 Nov |
1 |
| 218 |
21437121 | Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes. | 2009 Jun 12 |
2 |
| 219 |
17909087 | The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. | 2008 Jan |
3 |
| 220 |
17961192 | The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers. | 2008 Mar |
1 |
| 221 |
18042650 | Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes. | 2008 Feb |
3 |
| 222 |
18269436 | The islet enhancer vildagliptin: mechanisms of improved glucose metabolism. | 2008 Mar |
4 |
| 223 |
18284434 | Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea. | 2008 Nov |
1 |
| 224 |
18341596 | Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial. | 2008 Apr |
1 |
| 225 |
18422675 | Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited. | 2008 Nov |
2 |
| 226 |
18425967 | Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. | 2008 Apr 16 |
3 |
| 227 |
18471347 | Effect of food on the pharmacokinetics of a vildagliptin/metformin (50/1000 mg) fixed-dose combination tablet in healthy volunteers. | 2008 Jun |
1 |
| 228 |
18542012 | Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials. | 2008 Jul |
1 |
| 229 |
18561513 | Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin. | 2008 |
1 |
| 230 |
18577160 | Beyond insulin replacement: addressing the additional needs of the diabetes patient. | 2008 Jul |
1 |
| 231 |
18628530 | Incretin-based therapies in type 2 diabetes mellitus. | 2008 Oct |
1 |
| 232 |
18640590 | Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies. | 2008 Feb |
1 |
| 233 |
18640591 | DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients? | 2008 Feb |
1 |
| 234 |
18755155 | DPP4 inhibitors for diabetes--what next? | 2008 Dec 15 |
2 |
| 235 |
18769687 | Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes. | 2008 Jul 28 |
1 |
| 236 |
18793589 | Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes. | 2008 Jul |
3 |
| 237 |
18795210 | Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors. | 2008 Summer |
1 |
| 238 |
18827867 | Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet. | 2008 |
2 |
| 239 |
18840004 | New drugs for type 2 diabetes mellitus: what is their place in therapy? | 2008 |
1 |
| 240 |
18929237 | Dipeptidyl peptidase-4 as a new target of action for type 2 diabetes mellitus: a systematic review. | 2008 Nov |
1 |
| 241 |
18941490 | Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: a key intermediate for dipeptidyl peptidase IV inhibitors. | 2008 |
1 |
| 242 |
18947259 | New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies. | 2008 |
1 |
| 243 |
18973400 | Vildagliptin: a review of its use in the management of type 2 diabetes mellitus. | 2008 |
2 |
| 244 |
19017837 | Recent advances in the management of type 2 diabetes mellitus: a review. | 2008 Oct |
1 |
| 245 |
19022515 | Incretin-based therapies in type 2 diabetes: a review of clinical results. | 2008 Dec 15 |
1 |
| 246 |
19337535 | Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential. | 2008 |
2 |
| 247 |
20694081 | Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus. | 2008 Jun |
2 |
| 248 |
17244786 | The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. | 2007 Apr |
2 |
| 249 |
17277036 | Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. | 2007 Apr |
1 |
| 250 |
17300591 | Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug. | 2007 Mar |
1 |